Lexeo Therapeutics, Inc. (LXEO) Tops Q1 EPS by 49c
Tweet
Share
E-mailGet Alerts LXEO Hot Sheet
Join SI Premium – FREE
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) reported Q1 EPS of ($0.25), $0.49 better than the analyst estimate of ($0.74). Revenue for the quarter came in at $0.
For earnings history and earnings-related data on Lexeo Therapeutics, Inc. (LXEO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gordon Haskett cuts TJX Companies rating to Accumulate
- Alibaba (BABA) Misses Q2 EPS by 220c
- The Campbell's Co. (CPB) PT Raised to $18 at UBS
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
